Tumor Characterization Solutions for Clinical Trials, Cancer Research & Immuno-Oncology This presentation covers comprehensive tumor characterization solutions for clinical trials, cancer research and immune-oncology, including: specific challenges in sequencing and analyzing tumors for neoantigen identification; key differentiators of the ACE ImmunoID as compared to standard NGS offerings; and a review of the technical [...]
2016 CIMT: Validation of a Clinical 1400-Gene Assay for Genomic Profiling of Cancer from DNA and RNA
Genomic assays are increasingly used in oncology to guide clinical management and assess tumor responsiveness to novel therapeutics.
2015 AGBT: An Augmented, Extended Cancer Gene Panel Integrating DNA and RNA Sequencing Comprehensively Assesses Neoplastic Genetic Lesions
Through next-generation sequencing, we have come to understand cancer as a genomic disorder affecting key genes in cell growth and survival pathways.